Last $1.85 USD
Change Today -0.03 / -1.60%
Volume 48.7K
NEPT On Other Exchanges
Symbol
Exchange
Berlin
Toronto
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

neptune tech & bioressources (NEPT) Snapshot

Open
$1.85
Previous Close
$1.88
Day High
$1.94
Day Low
$1.83
52 Week High
01/23/14 - $3.61
52 Week Low
10/14/14 - $1.11
Market Cap
138.7M
Average Volume 10 Days
87.1K
EPS TTM
$-0.39
Shares Outstanding
75.0M
EX-Date
07/24/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEPTUNE TECH & BIORESSOURCES (NEPT)

Related News

No related news articles were found.

neptune tech & bioressources (NEPT) Related Businessweek News

No Related Businessweek News Found

neptune tech & bioressources (NEPT) Details

Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. It produces marine-derived omega-3 polyunsaturated fatty acids, including Neptune Krill Oil (NKO), a dietary supplement for heart, joint, women, and brain health; ECOKRILL Oil (EKO), a krill product; and Neptune Krill Aquatein (NKA), a protein ingredient used in the production of nursing feed for young animals. The company is also developing CaPre, which is in Phase II clinical trials for the management of mild to moderate hypertriglyceridemia and severe hypertriglyceridemia, as well as develops and commercializes pharmaceutical applications for cardiovascular and neurological diseases. Neptune Technologies & Bioressources sells its products in Canada, the United States, France, Belgium, Australia, and other countries. The company was founded in 1925 and is headquartered in Laval, Canada.

118 Employees
Last Reported Date: 10/14/14
Founded in 1925

neptune tech & bioressources (NEPT) Top Compensated Officers

Interim Chief Executive Officer, Interim Pres...
Total Annual Compensation: C$164.1K
Chief Global Strategic Officer
Total Annual Compensation: C$196.0K
Chief Operating Officer of Acasti
Total Annual Compensation: C$19.9K
Senior Vice-President of Global Sales
Total Annual Compensation: C$175.2K
Compensation as of Fiscal Year 2014.

neptune tech & bioressources (NEPT) Key Developments

Neptune Technologies & Bioressources Inc. Appoints Jim Hamilton as President and Chief Executive Officer and A Member of the Board, Effective February 2, 2015

Neptune Technologies & Bioressources Inc. announced that its Board of Directors has appointed Jim Hamilton as President and Chief Executive Officer of Neptune and a member of the Board, effective February 2, 2015. Mr. Hamilton is currently Vice President Human Nutrition and Health, North America, and President of DSM Nutritional Products USA, Inc.

Neptune Technologies & Bioressources, Inc. Reports Consolidated and Company Earnings Results for the Second Quarter and Six Months Ended August 31, 2014

Neptune Technologies & Bioressources, Inc. reported consolidated and company earnings results for the second quarter and six months ended August 31, 2014. For the quarter, the company reported revenues of $2,615,000 compared to $5,080,000 for the three-month period ended August 31, 2013. Adjusted EBITDA was negative of $10,132,000 versus negative $4,078,000 in the prior year. Net loss was $11,356,000 compared to a net loss of $1,779,000 in the prior year. For the quarter, consolidated revenues totaled $2,623,000 down from $5,346,000 for the quarter ended August 31, 2013. Adjusted EBITDA was negative of $12,875,000 versus negative of $6,055,000 in the prior year. Net loss was $14,848,000 versus a net loss of $5,052,000 in the prior year. The year over year decrease in adjusted EBITDA, on both a nutraceutical and consolidated basis, is largely due to incremental costs related to the plant ramp-up, an impairment on inventory resulting from the degradation of raw material, a bad debt charge for one significant customer, increased research and development (R&D) expenses along with higher marketing and advertising spending and training costs following the resumption of krill oil production. Partially offsetting this was a year-over-year reduction in legal fees. For the six months, the company reported revenues of $6,250,000, down from $11,165,000 for the six-month period ended August 31, 2013. Adjusted EBITDA was negative of $13,897,000 versus negative of $6,776,000 for the corresponding prior-year period. Net loss was $17,058,000 compared to net loss of $5,158,000 for the corresponding prior-year period. For the six months, consolidated revenues totaled $6,314,000 compared to $11,438,000 for the corresponding prior-year period. Adjusted EBITDA was negative of $18,647,000 versus negative of $10,038,000 for the corresponding prior-year period. Net loss was $19,217,000 versus a net loss of $10,467,000 in the corresponding prior-year period. The higher year over year net loss on a nutraceutical and consolidated basis was due to the factors highlighted for adjusted EBITDA. In addition, the prior year quarter also included insurance recoveries of $5.0 million relating to the Sherbrooke plant incident. Partially offsetting this was a year-over-year reduction in legal fees.

Neptune Technologies & Bioressources, Inc., Q2 2015 Earnings Call, Oct 15, 2014

Neptune Technologies & Bioressources, Inc., Q2 2015 Earnings Call, Oct 15, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEPT:US $1.85 USD -0.03

NEPT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Badger Meter Inc $59.39 USD +0.92
Enzymotec Ltd $7.55 USD +0.07
Itron Inc $43.35 USD +0.72
Targeted Medical Pharma Inc $0.33 USD +0.06
View Industry Companies
 

Industry Analysis

NEPT

Industry Average

Valuation NEPT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.7x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPTUNE TECH & BIORESSOURCES, please visit www.neptunebiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.